Advanced NSCLC: Interpreting Data From the POSEIDON Trial
A brief review of the POSEIDON trial, which analyzed durvalumab with or without tremelimumab in combination with chemotherapy in advanced NSCLC.
Recent Updates Translating Evidence Clinical Practice Interpreting Data From Lung Cancer Non Small Cell Lung Cancer
Source: onclive.com